P&G's Ebitda margin has also seen consistent improvement, with 250 bp expansion to ~23.5% during FY19-24.
(Photo Source: P&G official website)
With a portfolio of essentials and healthcare, P&G focuses on customer acquisition through product innovation. Penetration play is expected to continue at a stable pace, despite the high scope of user additions.